Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer
通过 STAT3/CD47-SIRPα 轴对 TAM 进行重编程可促进肺癌对 EGFR-TKI 产生获得性耐药
期刊:Cancer Letters
影响因子:9.1
doi:10.1016/j.canlet.2023.216205
Jiaye Lu, Jingwei Li, Ziyou Lin, Huaxuan Li, Linlin Lou, Wen Ding, Shumin Ouyang, Yonghui Wu, Yuanzhen Wen, Xiaobing Chen, Peibin Yue, Yuanxiang Wang, Peiqing Liu, Jinjian Lu, Jian Zhang, Weineng Feng, Xiaolei Zhang